The impact of drug quality ratings from health technology assessments on the adoption of new drugs by physicians in Germany
Year of publication: |
2020
|
---|---|
Authors: | Blankart, Katharina Elisabeth ; Stargardt, Tom |
Published in: |
Health Economics. - Wiley, ISSN 1099-1050, ZDB-ID 1483261-6. - Vol. 29.2020, S1 (15.06.), p. 63-82
|
Publisher: |
Wiley |
Saved in:
Online Resource
Saved in favorites
Similar items by person
-
Blankart, Katharina Elisabeth, (2020)
-
The impact of physician-level drug budgets on prescribing behavior
Blankart, Katharina, (2018)
-
The diffusion of generics after patent expiry in Germany
Blankart, Katharina, (2016)
- More ...